Thymosin Alpha-1: From Laboratory to Clinical Practice — Emerging Medical Applications
Updated review of thymosin alpha-1's expanding clinical applications: hepatitis B/C, cancer immunotherapy, vaccine adjuvancy, HIV immune reconstitution, and emerging uses in sepsis and immunodeficiency.
Quick Facts
What This Study Found
Updated review of thymosin alpha-1's expanding clinical applications: hepatitis B/C, cancer immunotherapy, vaccine adjuvancy, HIV immune reconstitution, and emerging uses in sepsis and immunodeficiency.
Key Numbers
How They Did This
research study.
Why This Research Matters
Relevant for peptide research.
The Bigger Picture
Advances peptide research.
What This Study Doesn't Tell Us
See abstract.
Questions This Raises
- ?Further research needed.
Trust & Context
- Key Stat:
- Key finding Updated review of thymosin alpha-1's expanding clinical applications: hepatitis B/C, cancer immunotherapy, vaccine adjuvancy, HIV immune reconstitutio
- Evidence Grade:
- emerging evidence.
- Study Age:
- Published in 2009.
- Original Title:
- From lab to bedside: emerging clinical applications of thymosin alpha 1.
- Published In:
- Expert opinion on biological therapy, 9(5), 593-608 (2009)
- Authors:
- Goldstein, Allan L(6), Goldstein, Adam L
- Database ID:
- RPEP-01483
Evidence Hierarchy
Frequently Asked Questions
What was studied?
Thymosin Alpha-1: From Laboratory to Clinical Practice — Emerging Medical Applications
What was found?
Updated review of thymosin alpha-1's expanding clinical applications: hepatitis B/C, cancer immunotherapy, vaccine adjuvancy, HIV immune reconstitution, and emerging uses in sepsis and immunodeficiency.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-01483APA
Goldstein, Allan L; Goldstein, Adam L. (2009). From lab to bedside: emerging clinical applications of thymosin alpha 1.. Expert opinion on biological therapy, 9(5), 593-608. https://doi.org/10.1517/14712590902911412
MLA
Goldstein, Allan L, et al. "From lab to bedside: emerging clinical applications of thymosin alpha 1.." Expert opinion on biological therapy, 2009. https://doi.org/10.1517/14712590902911412
RethinkPeptides
RethinkPeptides Research Database. "From lab to bedside: emerging clinical applications of thymo..." RPEP-01483. Retrieved from https://rethinkpeptides.com/research/goldstein-2009-from-lab-to-bedside
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.